{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:39:17Z","timestamp":1791398357984,"version":"4.3.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jaci.2011.04.030","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T05:51:23Z","timestamp":1307685083000},"page":"1356-1359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Gene therapy for primary adaptive immune deficiencies"],"prefix":"10.1016","volume":"127","author":[{"given":"Alain","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Hacein-Bey-Abina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.04.030_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.04.030_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.04.030_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.biochem.74.050304.091637","article-title":"Gene therapy: twenty-first century medicine","volume":"74","author":"Verma","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jaci.2011.04.030_bib4","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1073\/pnas.83.10.3194","article-title":"Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells","volume":"83","author":"Yu","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.04.030_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.04.030_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.04.030_bib7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.04.030_bib8","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.04.030_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.04.030_bib10","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.04.030_bib11","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.04.030_bib12","doi-asserted-by":"crossref","first-page":"e1000491","DOI":"10.1371\/journal.pgen.1000491","article-title":"Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy","volume":"5","author":"Dave","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2011.04.030_bib13","doi-asserted-by":"crossref","first-page":"e1001008","DOI":"10.1371\/journal.pcbi.1001008","article-title":"Deciphering the code for retroviral integration target site selection","volume":"6","author":"Santoni","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jaci.2011.04.030_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/ACI.0b013e32833fea85","article-title":"Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency","volume":"10","author":"Ferrua","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.04.030_bib15","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1182\/blood-2010-05-283523","article-title":"High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors","volume":"116","author":"Cattoglio","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.04.030_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semcancer.2010.06.003","article-title":"The genomic risk of somatic gene therapy","volume":"20","author":"Kustikova","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaci.2011.04.030_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.1717","article-title":"Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells","volume":"29","author":"Papapetrou","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2011.04.030_bib18","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nbt1353","article-title":"Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery","volume":"25","author":"Lombardo","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2011.04.030_bib19","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2004-12-4837","article-title":"Failure of SCID-X1 gene therapy in older patients","volume":"105","author":"Thrasher","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.04.030_bib20","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.04.030_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.04.030_bib22","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.04.030_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/mt.2008.118","article-title":"Stable and functional lymphoid reconstitution in Artemis-deficient mice following lentiviral Artemis gene transfer into hematopoietic stem cells","volume":"16","author":"Benjelloun","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2011.04.030_bib24","doi-asserted-by":"crossref","first-page":"16406","DOI":"10.1073\/pnas.0608130103","article-title":"Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer","volume":"103","author":"Mostoslavsky","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.04.030_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","article-title":"Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity","volume":"107","author":"Lagresle-Peyrou","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.04.030_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.iac.2010.02.002","article-title":"Gene therapy for primary immunodeficiencies","volume":"30","author":"Fischer","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2011.04.030_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2010.232","article-title":"Gene therapy of chronic granulomatous disease: the engraftment dilemma","volume":"19","author":"Grez","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2011.04.030_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/mt.2010.203","article-title":"Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression","volume":"19","author":"Hunter","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2011.04.030_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","article-title":"Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice","volume":"4","author":"Brown","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2011.04.030_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nbt.1775","article-title":"Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription","volume":"29","author":"Zhang","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2011.04.030_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaci.2011.04.030_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.04.030_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature09591","article-title":"Direct conversion of human fibroblasts to multilineage blood progenitors","volume":"468","author":"Szabo","year":"2010","journal-title":"Nature"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911006671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911006671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:30:40Z","timestamp":1758789040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911006671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0091674911006671"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.04.030","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for primary adaptive immune deficiencies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}